This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Fletcher, A. E. Articles by Neiss, A. M. Search for Related Content PubMed PubMed Citation Articles by Fletcher, A. E. Articles by Neiss, A. M.

Hypertension, Vol 19, 499-507, Copyright © 1992 by American Heart Association

ARTICLES

Quality of life with three antihypertensive treatments. Cilazapril, atenolol, nifedipine

AE Fletcher, CJ Bulpitt, DM Chase, WC Collins, CD Furberg, TK Goggin, AJ Hewett and AM Neiss
Department of Medicine, Royal Postgraduate Medical School, London, UK.

A multicenter, randomized double-blind study of 6 months' duration was performed in 540 patients (average age 54 years, 57% male) with mild-to- moderate essential hypertension to determine the relative effects on quality of life of cilazapril, atenolol, and nifedipine retard. Quality of life was assessed by using both a self-administered and an interviewer-administered questionnaire; the assessment included a complaint score (symptoms checklist), Health Status Index, assessment of work satisfaction, Psychological General Well-being Index, Profile of Mood States subscales, and life satisfaction assessment. Psychomotor function was measured by the Reitan Trail Making test B. At the end of the trial, diastolic blood pressure had fallen by an average of 15 mm Hg in all three groups, but significantly (p = 0.01) more patients taking cilazapril required the addition of a diuretic (36%) compared with those taking atenolol (25%) or nifedipine retard (24%). No significant differences in quality of life were observed between cilazapril and atenolol during the trial. Symptomatic complaints increased on nifedipine retard (p = 0.02) and contributed to a higher discontinuation rate (21% discontinued treatment compared with 13% and 14% taking atenolol and cilazapril, respectively, p = 0.04). However, a possible improvement in the fatigue subscale (p = 0.04) was also observed on nifedipine retard. The 95% confidence intervals showed that none of the drugs in this trial produced an effect equivalent to that previously reported between captopril and methyldopa in the Psychological General Well Being Index or between captopril and methyldopa or propranolol in Trail Making test B.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				M. S. Riedinger, K. A. Dracup, M.-L. Brecht, and for the SOLVD Investigators Quality of Life in Women With Heart Failure, Normative Groups, and Patients With Other Chronic Conditions Am. J. Crit. Care., May 1, 2002; 11(3): 211 - 219. [Abstract] [Full Text] [PDF]

				C J Bulpitt, A E Fletcher, L Dössegger, A Neiss, T Nielsen, and S Viergutz Quality of life in chronic heart failure: cilazapril and captopril versus placebo Heart, June 1, 1998; 79(6): 593 - 598. [Abstract] [Full Text]

				W. B. Stason, C. H. Schmid, D. Niedzwiecki, G. W. Whiting, D. Luo, S. D. Ross, and T. C. Chalmers Safety of Nifedipine in Patients With Hypertension : A Meta-Analysis Hypertension, July 1, 1997; 30(1): 7 - 14. [Abstract] [Full Text]

				W. B. Stason, C. H. Schmid, D. Niedzwiecki, G. W. Whiting, D. Luo, S. D. Ross, and T. C. Chalmers Safety of Nifedipine in Patients With Hypertension : A Meta-Analysis Hypertension, July 1, 1997; 30 (1): 7 - 14. [Abstract] [Full Text]

				R. H. Grimm Jr, G. A. Grandits, J. A. Cutler, A. L. Stewart, R. H. McDonald, K. Svendsen, R. J. Prineas, and P. R. Liebson Relationships of Quality-of-Life Measures to Long-term Lifestyle and Drug Treatment in the Treatment of Mild Hypertension Study Arch Intern Med, March 24, 1997; 157(6): 638 - 648. [Abstract] [PDF]

				N. C. Santanello, H. Guess, J. F. Heyse, N. M. Kaplan, D. R. Waud, A. Fletcher, J. E. Ware, M. A. Testa, and N. K. Hollenberg Captopril, Enalapril, and Quality of Life N. Engl. J. Med., August 12, 1993; 329(7): 505 - 507. [Full Text]